Analyzing data gathered between 2000 and 2008, researchers observed a significant decline in FOBT prevalence in higher socioeconomic status groups, but not in lower socioeconomic status groups. During this period, endoscopic colorectal cancer screening increased in all higher socioeconomic status subgroups while few lower socioeconomic status subgroups experienced increases in colorectal cancer endoscopic screening, and such increases were smaller than those observed in higher socioeconomic status subgroups.
The researchers concluded the following: “If national colorectal cancer screening goals are to be achieved in populations with lower access to colonoscopy, then annual high-sensitivity FOBT should be promoted as an immediately accessible and viable alternative.”
Related Articles on Colorectal Cancer Prevention:
Florida Hospital Flagler Now Offers Third Eye Colonoscopy
AGA Indentifies Five Treatments Physicians and Patients Should Question
Study: Colorectal Cancer Screenings Increase When Patients Given Options
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
